Get in while you can. Business is breakeven on its own without this result and current price essentially gives this result for free. IMO, a double or triple from here but go ahead and ask your AI friend of choice …
Up to 84% of GLP-1 induced weight loss retained with Revita® versus 46% with sham at one year in patients receiving complete duodenal ablations Next anticipated Revita® milestones are topline six-month randomized data from the REMAIN-1 Pivotal Cohort in early …
**But there is also some positive news.** At the end of the article, they themselves list several factors that could support Embecta: partnerships with more than **30 pharmaceutical companies**; joint projects related to **GLP-1 and pen needles**; emerging markets; cost …
[removed]
NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) ("VYNE" or the "Company") today announced that its Board of Directors has declared a special cash dividend (the "Cash Dividend") in connection with the previously announced merger …
Talk about your daily plays, ideas and strategies that do not warrant an actual post. This is the place to request buy/sell advice from the community. Remember to keep it civil. Trade responsibly.
$S.TO Trade Resumption - Trump's boy just bought 50% of the company Sherritt International is essentially a 100 year old Canadian based company with bigtime operations in Cuba, a leveraged bet on nickel and cobalt prices—and on the political and …
Whattup degens. I've been digging into juniors that are cheap relative to what's actually in the treasury and on the calendar. All three below are funded, have verifiable assets or contracts, and have dated news flow coming, no mystery miners, …
[removed]
[removed]